Chemoinformaics analysis of L-(+)-Acetylhomoserine
| Molecular Weight | 161.157 | nRot | 4 |
| Heavy Atom Molecular Weight | 150.069 | nRig | 2 |
| Exact Molecular Weight | 161.069 | nRing | 0 |
| Solubility: LogS | -0.776 | nHRing | 0 |
| Solubility: LogP | -3.075 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 21.6627 |
| nHD | 1 | BPOL | 14.2353 |
| QED | 0.535 |
| Synth | 2.547 |
| Natural Product Likeliness | 1.485 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.074 |
| HIA | 0.307 |
| CACO-2 | -5.872 |
| MDCK | 0.00503726 |
| BBB | 0.685 |
| PPB | 0.121797 |
| VDSS | 0.419 |
| FU | 0.885143 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.037 |
| CYP2c19-inh | 0.038 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.289 |
| CYP2d6-inh | 0.089 |
| CYP2d6-sub | 0.186 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.041 |
| CL | 5.708 |
| T12 | 0.637 |
| hERG | 0.022 |
| Ames | 0.031 |
| ROA | 0.017 |
| SkinSen | 0.186 |
| Carcinogencity | 0.059 |
| EI | 0.103 |
| Respiratory | 0.07 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.927616 |